H.B. No. 50 aims to enhance informed consent protocols for screening tests related to sexually transmitted diseases (STDs) in Texas. The bill introduces a new definition for "screening test" in the Health and Safety Code, specifying it as a rapid analytical procedure to determine the need for further diagnostic evaluation concerning certain infections. Additionally, it establishes a new section that mandates health care providers to submit blood samples for screening tests unless the individual opts out. Providers must obtain consent and inform individuals about the opt-out option before collecting samples.

Furthermore, if an individual tests positive for a screening test, the health care provider is required to offer information on available health care, education, prevention, and social support services. The executive commissioner of the Health and Human Services Commission is tasked with adopting rules to implement these provisions, with a deadline set for January 1, 2026. The bill also includes a provision that allows the commission to delay implementation if funding is not appropriated, with a requirement to report on the costs of implementation in future budget requests. The act is set to take effect on September 1, 2025.

Statutes affected:
Introduced: Health and Safety Code 85.002 (Health and Safety Code 85)
House Committee Report: Health and Safety Code 85.002 (Health and Safety Code 85)
Engrossed: Health and Safety Code 85.002 (Health and Safety Code 85)